Rictor/mTORC2 drives progression and therapeutic resistance...

  • Main
  • 2016 / 04
  • Rictor/mTORC2 drives progression and therapeutic resistance...

Rictor/mTORC2 drives progression and therapeutic resistance of HER2-amplified breast cancers

Morrison-Joly, M., Hicks, D. J., Jones, B., Sanchez, V., Estrada, M. V., Young, C., Williams, M., Rexer, B. N., Sarbassov, D. D., Muller, W. J., Brantley-Sieders, D., Cook, R. S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-15-3393
Date:
April, 2016
File:
PDF, 3.33 MB
english, 2016
Conversion to is in progress
Conversion to is failed